Preferential expression of Th2-type chemokine and its receptor in atopic dermatitis

International Immunology

Volumn 14, Issue 12, 2002, Pages 1431-1438

  Uchida, Takafumi ^a   Suto, Hajime ^a   Ra, Chisei ^a   Ogawa, Hideoki ^a   Kobata, Tetsuji ^b   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Chemokine; Chemokine receptor; Th1; Th2

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CYTOKINE; PSORALEN DERIVATIVE; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ADULT; ATOPIC DERMATITIS; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; EOSINOPHIL; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SKIN DISEASE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; PUNCH BIOPSY; PUVA; REVIEW; SKIN DEFECT; SYMPTOM; T LYMPHOCYTE; TH2 CELL; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; CHEMOKINES, CC; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; PSORALENS; PUVA THERAPY; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SKIN; TH2 CELLS; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS;

EID: 0036910184     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxf109     Document Type: Review

References (62)

1. Hanifin, J. and Rajka, G. 1980. Diagnostic features of atopic dermatitis. Acta Dermatol. Venereol. Suppl. 92:44.
2. Japanese Dermatological Association. 1995. Criteria for the diagnosis of atopic dermatitis. J. Dermatol. 22:966.
3. Rudikoff, D. and Lebwohl, M. 1998. Atopic dermatitis. Lancet 51:1715.
4. Ogawa, H. 1990. Fundamental pathogenesis of atopic dermatitis and that of alopecia areata (Presidential Address in the 15th Annual Meeting of the Japanese Society for Investigative Dermatology, 1998). J. Dermatol. Sci. 1:375.
5. Ogawa, H. and Yoshiike, T. 1993. A speculative view of atopic dermatitis. J. Dermatol. Sci. 5:197.
6. Yoshiike, T., Aikawa, Y., Sindhvananda, J., Suto, H., Nishimura, K., Kawamoto, T. and Ogawa, H. 1993. Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline. J. Dermatol. Sci. 5:92.
7. Aikawa, Y. and Yoshiike, T. 1997. Studies of stratum corneum permeability in normal individuals and patients with atopic dermatitis utilizing a diffusion chamber system. Jpn. J. Dermatol. 107:1473.
8. Imokawa, G., Abe, A., Jin, K., Higaki, Y., Kawashima, M. and Hidano, A. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96:523.
9. Saurat, J. 1985. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Dermatol. Venereol. Suppl. 114:125.
10. Shirakawa, T., Mao, X., Sasaki, S., Enomoto, T., Kawai, M., Morimoto, K. and Hopkin, J. 1996. Association between atopic asthma and a coding variant of Fc epsilon RI beta in a Japanese population. Hum. Mol. Genet. 5:2068.
11. Thestrup-Pedersen, K., Ellingsen, A. R., Olesen, A. B., Lund, M. and Kaltoft, K. 1997. Atopic dermatitis may be a genetically determined dysmaturation of ectodermal tissue, resulting in disturbed T-lymphocyte maturation. A hypothesis. Acta Dermatol. Venereol. Suppl. 77:20.
12. Greenhill, M. and Finesinger, J. 1942. Neurotic symptoms and emotional factors in atopic dermatitis. Arch. Dermatol. Syph. 46:187.
13. Leung, D., Rhodes, A., Geha, R., Schneider, L. and Ring, J. 1993. Atopic dermatitis (atopic eczema). In Fitzpatrick, T., Eisen, A., Wolff, K., Freedberg, I. and Austen, K., eds, Dermatology in General Medicine, 4th edn, p. 1543. McGraw-Hill, New York.
14. Herz, U., Bunikowski, R. and Renz, H. 1998. Role of T cells in atopic dermatitis. Int. Arch. Allergy Immunol. 115:179.
15. H2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103:1103.
16. h2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19:359.
17. H2 subsets: doubt no more. Immunol. Today 12:256.
18. Metzger, H. 1992. The receptor with high affinity for IgE. Immunol. Rev. 125:37.
19. Kitagaki, H., Ono, N., Hayakawa, K., Kitazawa, T., Watanabe, K. and Shiohara, T. 1997. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 159:2484.
20. Grewe, M., Gyufko, K., Schopf, E. and Krutmann, J. 1994. Lesional expression of interferon-gamma in atopic eczema. Lancet 343:25.
21. h1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97:828.
22. Campbell, J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D., Warnke, R., Ruffing, N., Kassam, N., Wu, L. and Butcher, E. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776.
23. h2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104:1097.
24. h1 lymphocytes. Nature 391:344.
25. h2 cells toward antigen-presenting cells by the CC chemokine thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:81.
26. Sallusto, F., Lenig, D., Mackay, C. and Lanzavecchia, A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
27. Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L. and Pathak, M. A. 1974. Photochemotherapy of psoriasis with oral methoxalen and longwave ultraviolet light. N. Engl. J. Med. 291:1207.
28. Suto, H., Yoshiike, T., Aikawa, Y., Kawamoto, T. and Ogawa, H. 1998. Combination of photochemotherapy (PUVA) with short-term oral administration of corticosteroid in patients with Atopic dermatitis. Jpn. J. Dermatol. 108:1155.
29. Minaguchi, S., Yoshiike, T., Aikawa, Y., Nakajima, S., Sindhvananda, J. and Ogawa, H. 1990. Topical psorallen photochemotherapy for severe atopic dermatitis: an analysis of correlation between effectiveness of PUVA therapy and clinical parameters. Jpn. J. Dermatol. 100:1251.
30. + T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J. Invest. Dermatol. 98:59.
31. h1 subset. J. Invest. Dermatol. 102:145.
32. Sallusto, F., Mackay, C. and Lanzavecchia, A. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 27:2005.
33. h cells. J. Immunol. 161:5111.
34. h1 cells. J. Immunol. 161:547.
35. h2s. J. Exp. Med. 187:129.
36. Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S. and Yoshie, O. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272:15036.
37. Imai, T., Chantry, D., Raport, C., Wood, C., Nishimura, M., Godiska, R., Yoshie, O. and Gray, P. 1998. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273:1764.
38. Liao, F., Rabin, R., Yannelli, J., Koniaris, L., Vanguri, P. and Farber, J. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182:1301.
39. Knop, J. and Enk, A. 1995. Cellular and molecular mechanisms in the induction phase of contact sensitivity. Int. Arch. Allergy Immunol. 107:231.
40. Raychaudhuri, S., Farber, E., Schall, T., Ruff, M. and Pert, C. 1999. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Dermatol. Venereol. 79:9.
41. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C., Langen, H., Thelen, M. and Baggiolini, M. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185:2171.
42. Gerber, B., Zanni, M., Uguccioni, M., Loetscher, M., Mackay, C., Pichler, W., Yawalkar, N., Baggiolini, M. and Moser, B. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol. 00:836.
43. Suto, H., Matsuda, H., Mitsuishi, K., Hira, K., Uchida, T., Unno, T., Ogawa, H. and Ra, C. 1999. NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol. 120 (Suppl. 1):70.
44. Matsuda, H., Watanabe, N., Geba, G., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P. and Ra, C. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:461.
45. H2 cell localization and delivery of B cell help in vivo. Science 286:2159.
46. Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M. and Lanzavecchia, A. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617.
47. Schroder, J. and Mochizuki, M. 1999. The role of chemokines in cutaneous allergic inflammation. J. Biol. Chem. 380:889.
48. Chen H., Centola M., Altschul S. and Metzger H. 1998. Characterization of gene expression in resting and activated mast cells. J. Exp. Med. 188:1657.
49. Irani, A., Sampson, H. and Schwartz, L. 1989. Mast cells in atopic dermatitis. Allergy 44 (Suppl. 9):31.
50. Leung, D. 1993. Role of IgE in atopic dermatitis. Curr. Opin. Immunol. 5:956.
51. Tonnel, A., Gosset, P., Molet, S., Tillie-Leblond, I., Jeannin, P. and Joseph, M. 1996. Interactions between endothelial cells and effector cells in allergic inflammation. Ann. NY Acad. Sci. 796:9.
52. Holgate, S. 1996. The immunopharmacology of mild asthma. J Allergy Clin Immunol. 98 (5 Pt 2):S7.
53. Gruber, B., Kew, R., Jelaska, A., Marchese, M., Garlick, J., Ren, S., Schwartz, L. and Korn, J. 1997. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 158:2310.
54. Gordon, J. and Galli, S. 1991. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J. Exp. Med. 174:103.
55. Groves, R., Allen, M., Ross, E., Barker, J. and MacDonald, D. 1995. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132:345.
56. Yamada, H., Matsukura, M., Yudate, T., Chihara, J., Stingl, G. and Tezuka, T. 1997. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int. Arch. Allergy Immunol. 114 (Suppl. 1):28.
57. Furue, M., Sugiyama, H., Tsukamoto, K., Ohtake, N. and Tamaki, K. 1994. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J. Dermatol. Sci. 7:89.
58. Toda, K., Danno, K., Tachibana, T. and Horio, T. 1986. Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. J. Invest. Dermatol. 87:113.
59. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J. and Luger, T. 1990. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172:1609.
60. Sauder, D. 1990. The role of epidermal cytokines in inflammatory skin diseases. J. Invest. Dermatol. 95:27S.
61. Boorsma, D., Flier, J., Sampat, S., Ottevanger, C., de Haan, P., Hooft, L., Willemze, R., Tensen, C. and Stoof, T. 1998. Chemokine IP-10 expression in cultured human keratinocytes. Arch. Dermatol. Res. 290:335.
62. Kapp, A., Kirnbauer, R., Luger, T. and Schopf, E. 1989. Altered production of immuno-modulating cytokines in patients with atopic dermatitis. Acta Dermatol. Venereol. Suppl. 144:97.